Objectives: The purposes of the present study were to (1) analyze the relationship between clinical oral health status and subjective oral health status, (2) explore the association between perceived oral symptoms and subjective oral health status, and (3) investigate the effects of factors on subjective oral health status. Methods: A total of 771 subjects, aged over 35 years of age, from a dental hospital in Gwangju metropolitan city, were surveyed cross-sectionally using a self-report questionnaire. We investigated the relationship of subjective oral health status with clinical oral health status, and with perceived oral symptoms using a Chi-squared test (P<0.05). To investigate the effects of factors on subjective oral health status relationship, a logistic regression analysis was performed. Results: The odds ratios of subjective oral health status between ‘Bad’ vs ‘Good’ were as follows: frequent oral concern, 43.41; occasional oral concern, 2.94; toothache, 6.08; hypersensitivity to coldness, 2.13; 1-3 year’s periodic preventive oral care, 0.19; 4-7 and periodic preventive oral care, 0.14. Conclusions Periodic preventive oral care appears to be associated with self-rated subjective oral health status.

BACKGROUND: Epidemiological studies suggest that serum calcium levels correlate with cardiovascular events. An ankle-brachial index (ABI) between 0.9 and 1.00 is a surrogate estimation of preclinical peripheral arterial disease (PAD). Prior studies have shown that an ABI of 0.9–1.0 is also associated with endothelial dysfunction. Therefore, we sought to investigate the relationship between serum calcium levels and preclinical PAD in apparently healthy Korean individuals. METHODS: We evaluated the association between serum calcium levels and preclinical PAD in 596 participants (334 males, 262 females) in a health examination program. Preclinical PAD was defined by an ABI of 0.9–1.0. Multiple logistic regression analysis was used to determine whether the serum calcium level was an independent determinant of preclinical PAD. RESULTS: The overall prevalence of preclinical PAD was 14.3%. The mean age was 44.0±12.5 years in the non-PAD group and 48.3±11.4 years in the preclinical PAD group (P=0.001). After adjusting for age, gender, systolic blood pressure, fasting plasma glucose, high-density lipoprotein cholesterol, triglycerides, C-reactive protein, g-glutamyltransferase, uric acid, hypertension medication, diabetes medication, and hyperlipidemia medication, the odds ratio (95% confidence intervals) for preclinical PAD was 2.28 (1.02–5.11) with a 1-mg/dL increase in the serum calcium. CONCLUSION: These findings suggest that increased serum calcium is independently and positively associated with preclinical PAD regardless of the presence of classic cardiovascular risk factors.
Ankle Brachial Index ; Blood Glucose ; Blood Pressure ; C-Reactive Protein ; Calcium* ; Cardiovascular Diseases ; Cholesterol ; Epidemiologic Studies ; Fasting ; Humans ; Hyperlipidemias ; Hypertension ; Lipoproteins ; Logistic Models ; Male ; Odds Ratio ; Peripheral Arterial Disease* ; Prevalence ; Risk Factors ; Triglycerides ; Uric Acid

OBJECTIVE: The purpose of the present study was to compare the diagnostic performance of initial procalcitonin, lactate, and high-sensitive C-reactive protein (hsCRP) for predicting bacteremia in female patients with acute pyelonephritis (APN). METHODS: We conducted a retrospective study of female APN patients who visited the emergency department (ED) at the studied hospital between January 2015 and December 2016. The main outcome was bacteremia, which was reported via the first blood culture at ED. The patient demographics, co-morbidities, physiologies, and laboratory variables including initial procalcitonin, lactate, and hsCRP levels, were collected and analyzed to identify associations with the presence of bacteremia. The area under the receiver operating curve (AUROC) and sensitivity (SE)/specificity (SP) were calculated for each variable. RESULTS: During the study period, 282 patients were enrolled. A total of 105 (37.2%) patients had bacteremia. Escherichia coli was the most frequent pathogen. The AUROC was 0.70 (0.63–0.76), 0.70 (0.63–0.76), and 0.56 (0.49–0.63) for the procalcitonin, lactate, and hsCRP, respectively. At a cut-off value of 0.163 ng/mL, the procalcitonin level predicted bacteremia, with a SE/SP of 95.2%/22.6%, respectively. At a cut-off value of 0.7 mmol/L, the lactate level predicted bacteremia with a SE/SP of 96.2%/20.9%, respectively. The combination of a procalcitonin level >0.447 ng/mL or a lactate level >0.7 mmo/L was chosen, as they showed 100% SE and a 100% negative predictive value. CONCLUSION: The initial serum procalcitonin and lactate levels showed similar and fair discriminative performance for predicting bacteremia in female APN patients, while the hsCRP level showed poor performance. The combination of procalcitonin and lactate (procalcitonin level≤0.447 ng/mL and lactate≤0.7 mmol/L) can be used to identify patients at low risk of bacteremia.
Bacteremia ; C-Reactive Protein ; Demography ; Emergency Service, Hospital ; Escherichia coli ; Female ; Humans ; Lactic Acid ; Pyelonephritis ; Retrospective Studies

Aging has become a global problem, and the interest in healthy aging is growing. Healthy aging involves a focus on the maintenance of the function and well-being of elderly adults, rather than a specific disease. Thus, the management of frailty, which is an accumulated decline in function, is important for healthy aging. The adaptation method was used to develop clinical practice guidelines on frailty management that are applicable in primary care settings. The guidelines were developed in three phases: preparation (organization of committees and establishment of the scope of development), literature screening and evaluation (selection of the clinical practice guidelines to be adapted and evaluation of the guidelines using the Korean Appraisal of Guidelines for Research and Evaluation II tool), and confirmation of recommendations (three rounds of Delphi consensus and internal and external reviews). A total of 16 recommendations (five recommendations for diagnosis and assessment, 11 recommendations for intervention of frailty) were made through the guideline development process. These clinical practice guidelines provide overall guidance on the identification, evaluation, intervention, and monitoring of frailty, making them applicable in primary care settings. As aging and “healthy aging” become more and more important, these guidelines are also expected to increase in clinical usefulness.